Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Unravelling Effectiveness of a Nurse-led Behavior Change Intervention to Enhance Physical Activity in Patients

16. oktober 2018 oppdatert av: H.Westland, UMC Utrecht

Unravelling Effectiveness of a Nurse-led Behavior Change Intervention to Enhance Physical Activity in Patients With a Cardiovascular Risk: a Clustered-randomized Controlled Trial in Primary Care

A two-armed, cluster randomized controlled trial will be conducted comparing the Activate intervention with care as usual in 31 general practices in the Netherlands, in which approximately 279 patients at risk for cardiovascular disease will participate. The Activate intervention focuses on increasing physical activity and is developed using the Behavior Change Wheel (BCW). The activate intervention consists of four nurse-led consultations divided over a 3-months period. Primary outcome is the level of physical activity measured with an accelerometer. Potential effect modifiers are age, body mass index, level of education, social support, depression, patient-provider relationship and baseline amount of minutes of physical activity. Data will be collected at baseline, at 3 months and at 6 months of follow up.

Nurses will be trained in delivering the intervention by a one-day training and coaching sessions supervised. A process evaluation will be conducted.

Studieoversikt

Status

Fullført

Intervensjon / Behandling

Detaljert beskrivelse

Self-management interventions are considered effective in chronic disease patients, but trials have shown inconsistent results and it is unknown which patients benefit most. Adequate self-management requires behaviour change in patients and in healthcare providers to equip them in supporting patients in changing their behaviour. To unravel effectiveness of self-management, a nurse-led intervention was developed targeting at one self-management behaviour, namely physical activity, in primary care patients at risk for cardiovascular disease: the Activate intervention. This study aims to evaluate the effectiveness of the Activate intervention, to identify which patient-related characteristics modify change in physical activity levels in patients at risk for CVD in primary care, and to conduct a process evaluation.

A two-armed, cluster randomized controlled trial will be conducted comparing the Activate intervention with care as usual in 31 general practices in the Netherlands, in which approximately 300 patients at risk for cardiovascular disease will participate. The Activate intervention focuses on increasing physical activity and is developed using the Behavior Change Wheel (BCW). The activate intervention consists of four nurse-led consultations divided over a 3-months period in which 17 behaviour change techniques (BCTs) are integrated. Primary outcome is the level of physical activity measured with an accelerometer . Potential effect modifiers are age, body mass index, level of education, social support, depression, patient-provider relationship and baseline amount of minutes of physical activity. Data will be collected at baseline, at 3 months and at 6 months of follow up.

Subsequently, the BCW was applied to analyse what behavior change is needed in nurses to deliver the Activate intervention adequately. This resulted in a one-day training and coaching sessions supervised by a health psychologist and included 21 BCT.

A process evaluation will be conducted to evaluate the training of nurses, fidelity, dose and reach of the Activate intervention, identify barriers and facilitators for implementation and to assess participants' satisfaction.

Studietype

Intervensjonell

Registrering (Faktiske)

195

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Utrecht, Nederland, 3531 HX
        • GP Lombok
    • Brabant
      • Asten, Brabant, Nederland, 5721CM
        • GP Lienderweg
      • Drunen, Brabant, Nederland, 5151 HA
        • GP Timmerman
      • s Hertogenbosch, Brabant, Nederland, 5235KG
        • GP Emmers
    • Gelderland
      • Ede, Gelderland, Nederland, 6713 NS
        • GP Klaar and Vincent
      • Hoevelaken, Gelderland, Nederland, 3871EE
        • GP Parklaan
    • Gerlderland
      • Buren, Gerlderland, Nederland, 4116CW
        • GP Buren
    • Noord Holland
      • Hilversum, Noord Holland, Nederland, 1223DT
        • GP Seinhorst
    • Noord-Holland
      • Amstelveen, Noord-Holland, Nederland, 1186PJ
        • GP Tjin a Ton and Parlevliet
      • Bennebroek, Noord-Holland, Nederland, 2121BB
        • GP De Kennemerpoort
      • Heerhugowaard, Noord-Holland, Nederland, 1701 ER
        • GP Odijk-Visser
      • Heerhugowaard, Noord-Holland, Nederland, 1701ER
        • GP Munster
      • Hilversum, Noord-Holland, Nederland, 1215EK
        • GP Eedenburgh
      • Koedijk, Noord-Holland, Nederland, 1831EK
        • GP Koedijk
      • Nieuw Vennep, Noord-Holland, Nederland, 2152CA
        • GP De Hollenhorst
      • Wassenaar, Noord-Holland, Nederland, 2241KE
        • GP Spelt
    • Overijssel
      • Colmschate, Overijssel, Nederland, 7429BG
        • GP Jonker
      • Kampen, Overijssel, Nederland, 8265 DN
        • GP Amarant
      • Markelo, Overijssel, Nederland, 7475AG
        • GP Rosing and Bruins Slot
      • Zwolle, Overijssel, Nederland, 8042AD
        • GP Blanker, Thiele, Brand
    • Utrecht
      • Bilthoven, Utrecht, Nederland, 3723RC
        • GP Provostlaan
      • Bunnik, Utrecht, Nederland, 3981EV
        • GP van Steenis
      • De BIlt, Utrecht, Nederland, 3732BG
        • GP De Bilt
      • Leusden, Utrecht, Nederland, 3831JR
        • GP Tolgaarde
      • Odijk, Utrecht, Nederland, 3984MA
        • GP Odijk
      • Woudenberg, Utrecht, Nederland, 3931 KJ
        • GP De Schans
    • Zuid-Holland
      • Alphen aan den Rijn, Zuid-Holland, Nederland, 2408 LA
        • GP Sparreboom
      • Boskoop, Zuid-Holland, Nederland, 2771 EN
        • GP Wiechen
      • Schoonrewoerd, Zuid-Holland, Nederland, 4145NV
        • GP De Wiel
      • The Hague, Zuid-Holland, Nederland, 2525CE
        • GP Mozaiek
      • The Hague, Zuid-Holland, Nederland, 2593WB
        • GP Loudon

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

40 år til 75 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

Aged 40-75

AND at least one of the following criteria:

  • have a high blood pressure (≥ 140 mmHg) or are already treated for high blood pressure
  • have a high total cholesterol (≥ 6.5 mmol/l) or already treated for high cholesterol
  • have diabetes mellitus type 2 (DM2)
  • have a positive family history of CVD AND Do not meet the Dutch Norm for Healthy Exercise according to the Short QUestionnaire to Asses Health (SQUASH).

Exclusion Criteria:

  • unable to give informed consent (eg. due to cognitive impairment),
  • unable to speak, write and read Dutch,
  • have contra-indications to increase their physical activity level (eg. unstable angina pectoris, unstable heart failure, acute illness)
  • have a terminal illness or have severe psychiatric illness or chronic disorder(s) that seriously influence the ability to improve their psychical activity level.
  • patients should not have participated in a program to increase their level of physical activity in the past 2 years.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Intervention: Activate intervention
Participants in the intervention arm will visit their primary care nurse four times in a three-month period for structured and comprehensive support in achieving an improved level of physical activity.
The Activate intervention consists of four nurse-led consultations in a thee-month period. In the consultations patients receive structured and comprehensive support in achieving an improved level of physical activity. The Behavior Change Wheel was used to develop the Activate intervention, and led to a selection of 17 behavior change techniques, which are integrated in the Activate intervention
Ingen inngripen: Control
Patients in the control arm will receive care as usual.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
level of physical activity measured with the Personal Activity Monitor (PAM AM300)
Tidsramme: baseline - 6 months of follow up
The amount of minutes of physical activity in the moderate (3-6 METabolic equivalent (METS)) and vigorous categories (≥6 METS) at 6 months of follow up will be considered as primary outcome measure. Patients will be asked to wear the accelerometer during 7 consecutive days for 12 hours a day at baseline (T0), 3 months of follow up (T1) and at 6 months of follow up (T2).
baseline - 6 months of follow up

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Sedentary behaviour using the accelerometer using amount of minutes in the sedentary category (<1,8 METS)
Tidsramme: baseline -3 months and 6 months of follow up
Sedentary behaviour using the accelerometer using amount of minutes in the sedentary category (<1,8 METS)
baseline -3 months and 6 months of follow up
Self-efficacy for physical activity using the Exercise Self-efficacy Scale (ESS)
Tidsramme: baseline - 3 months and 6 months of follow up
Self-efficacy for physical activity using the Exercise Self-efficacy Scale (ESS), baseline, T0, T1, T2
baseline - 3 months and 6 months of follow up
Patient activation using the Patient Activation Measure (PAM-13)
Tidsramme: baseline -3 months and 6 months of follow up
Patient activation using the Patient Activation Measure (PAM-13)
baseline -3 months and 6 months of follow up
Health status using the EQ-5D
Tidsramme: baseline - 6 months of follow up
Health status using the EQ-5D
baseline - 6 months of follow up

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Potential effect modifier: age
Tidsramme: baseline
does age modify change in physical activity level
baseline
Potential effect modifier: depression using the Hospital Anxiety and Depression Scale (HADS)
Tidsramme: baseline
does depression modify change in physical activity level
baseline
Potential effect modifier: Body Mass Index (BMI)
Tidsramme: baseline
does BMI modify change in physical activity level
baseline
Potential effect modifier: level of education
Tidsramme: baseline
does education level modify change in physical activity
baseline
Potential effect modifier: social support using Multidimensional Scale of Perceived Social Support (MSPSS)
Tidsramme: baseline,
does social support modify change in level of physical activity
baseline,
Potential effect modifier: patient-provider relationship using the Communication Assessment Tool (CAT)
Tidsramme: baseline, 3 months and 6 months of follow up
does the patient-provider relationship modify change in level of physical activity
baseline, 3 months and 6 months of follow up
Potential effect modifier: baseline amount of minutes of moderate to vigorous level of physical activity using the PAM AM300
Tidsramme: baseline
does baseline amount of minutes of moderate to vigorous level of physical activity modify change in level of physical activity
baseline

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Studiestol: Marieke J. Schuurmans, PhD, UMC Utrecht
  • Hovedetterforsker: Heleen Westland, MSc, UMC Utrecht
  • Hovedetterforsker: Irene D Bos-Touwen, MSc, UMC Utrecht
  • Studiestol: Jaap CA Trappenburg, PhD, UMC Utrecht
  • Studiestol: Carin D Schröder, PhD, UMC Utrecht

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. mars 2016

Primær fullføring (Faktiske)

1. november 2017

Studiet fullført (Faktiske)

1. november 2017

Datoer for studieregistrering

Først innsendt

25. mars 2016

Først innsendt som oppfylte QC-kriteriene

30. mars 2016

Først lagt ut (Anslag)

31. mars 2016

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. oktober 2018

Siste oppdatering sendt inn som oppfylte QC-kriteriene

16. oktober 2018

Sist bekreftet

1. oktober 2018

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

IPD-planbeskrivelse

Not yet

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

3
Abonnere